HR Execs on the Move

Genzyme

www.genzyme.com

 
Genzyme Corporation is a fully owned subsidiary of Sanofi. Before its acquisition in 2011, Genzyme was an American biotechnology company based in Cambridge, Massachusetts. In 2010, Genzyme was the world`s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 40 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories, its products are sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenues with more than 25 products in the market. In 2006 and 2007 Genzyme was named one of Fortune Magazine`s “100 Best Companies to ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.genzyme.com
  • 500 Kendall Street
    Cambridge, MA USA 08807
  • Phone: 908.981.5000

Executives

Name Title Contact Details
Michael O'Callaghan
 VP of R&D Profile
Tom Scholl
 VP R&D Profile
Karen Bissonnette
 Manager CMO QA Profile
Priscilla Lim
 Senior Director - Human Resources - Japan - Asia Pacific Profile
Michelle Smith
 Senior Director Human Resource, Genzyme R&D, Global Medical Affairs Profile

Similar Companies

Micromedex

Micromedex is a Greenwood Vlg, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AerovectRx Corporation

AerovectRx Corporation is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

People

People, Pets and Vets is a doctor-led organization that partners with veterinarians to help them reach their full potential.

Providien

Providien is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.